Visceral adipose tissue-derived serine protease inhibitor (vaspin), a 392–395 amino acid protein, has been identified as a compensatory adipokine that improves insulin sensitivity and anti-inflammatory response in obesity, as well as its metabolic consequences [13, 14]. Here, SERPINA12 is linked to obesity due to melanocortin 4 receptor deficiency.